肝切除术后急性肝功能衰竭后的抢救肝移植:系统回顾和汇总分析

IF 3.6 2区 医学 Q2 IMMUNOLOGY
Roberta Angelico , Leandro Siragusa , Matteo Serenari , Irene Scalera , Emanuele Kauffman , Quirino Lai , Alessandro Vitale , on behalf of the Italian Chapter of IHPBA (AICEP, Associazione Italiana di Chirurgia Epatobilio-Pancreatica)
{"title":"肝切除术后急性肝功能衰竭后的抢救肝移植:系统回顾和汇总分析","authors":"Roberta Angelico ,&nbsp;Leandro Siragusa ,&nbsp;Matteo Serenari ,&nbsp;Irene Scalera ,&nbsp;Emanuele Kauffman ,&nbsp;Quirino Lai ,&nbsp;Alessandro Vitale ,&nbsp;on behalf of the Italian Chapter of IHPBA (AICEP, Associazione Italiana di Chirurgia Epatobilio-Pancreatica)","doi":"10.1016/j.trre.2023.100773","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p><span><span><span>Post-hepatectomy liver failure is a severe complication after major liver resection and is associated with a high mortality rate. Nevertheless, there is no effective treatment for </span>severe liver failure. In such a setting, rescue </span>liver transplantation (LT) is used only in extraordinary cases with unclear results. This </span>systematic review aims to define indication of LT in post-hepatectomy liver failure and post-LT outcomes, in terms of patient and disease-free survivals, to assess the procedure's feasibility and effectiveness.</p></div><div><h3>Methods</h3><p>A systematic review of all English language full-text articles published until September 2022 was conducted. Inclusion criteria were articles describing patients undergoing LT for post-hepatectomy liver failure after liver resection, which specified at least one outcome of interest regarding patient/graft survival, postoperative complications<span>, tumour recurrence and cause of death. A pseudo-individual participant data meta-analysis was performed to analyse data. Study quality was assessed with MINORS system. PROSPERO CRD42022349358.</span></p></div><div><h3>Results</h3><p><span>Postoperative complication rate was 53.6%. All patients transplanted for benign indications survived. For malignant tumours, 1-, 3- and 5-year overall survival was 94.7%, 82.1% and 74.6%, respectively. The causes of death were tumour recurrence in 83.3% of cases and infection-related in 16.7% of LT recipients. At Cox regression, being transplanted for unconventional malignant indications (colorectal liver metastasis, cholangiocarcinoma) was a risk factor for death HR = 8.93 (95%CI = 1.04–76.63; </span><em>P</em>-value = 0.046). Disease-free survival differs according to different malignant tumours (P-value = 0.045).</p></div><div><h3>Conclusions</h3><p>Post-hepatectomy liver failure is an emergent indication for rescue LT, but it is not universally accepted. In selected patients, LT can be a life-saving procedure with low short-term risks. However, special attention must be given to long-term oncological prognosis before proceeding with rescue LT in an urgent setting, considering the severity of liver malignancy, organ scarcity, the country's organ allocation policies and the resource of living-related donation.</p></div>","PeriodicalId":48973,"journal":{"name":"Transplantation Reviews","volume":"37 3","pages":"Article 100773"},"PeriodicalIF":3.6000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Rescue liver transplantation after post-hepatectomy acute liver failure: A systematic review and pooled analysis\",\"authors\":\"Roberta Angelico ,&nbsp;Leandro Siragusa ,&nbsp;Matteo Serenari ,&nbsp;Irene Scalera ,&nbsp;Emanuele Kauffman ,&nbsp;Quirino Lai ,&nbsp;Alessandro Vitale ,&nbsp;on behalf of the Italian Chapter of IHPBA (AICEP, Associazione Italiana di Chirurgia Epatobilio-Pancreatica)\",\"doi\":\"10.1016/j.trre.2023.100773\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p><span><span><span>Post-hepatectomy liver failure is a severe complication after major liver resection and is associated with a high mortality rate. Nevertheless, there is no effective treatment for </span>severe liver failure. In such a setting, rescue </span>liver transplantation (LT) is used only in extraordinary cases with unclear results. This </span>systematic review aims to define indication of LT in post-hepatectomy liver failure and post-LT outcomes, in terms of patient and disease-free survivals, to assess the procedure's feasibility and effectiveness.</p></div><div><h3>Methods</h3><p>A systematic review of all English language full-text articles published until September 2022 was conducted. Inclusion criteria were articles describing patients undergoing LT for post-hepatectomy liver failure after liver resection, which specified at least one outcome of interest regarding patient/graft survival, postoperative complications<span>, tumour recurrence and cause of death. A pseudo-individual participant data meta-analysis was performed to analyse data. Study quality was assessed with MINORS system. PROSPERO CRD42022349358.</span></p></div><div><h3>Results</h3><p><span>Postoperative complication rate was 53.6%. All patients transplanted for benign indications survived. For malignant tumours, 1-, 3- and 5-year overall survival was 94.7%, 82.1% and 74.6%, respectively. The causes of death were tumour recurrence in 83.3% of cases and infection-related in 16.7% of LT recipients. At Cox regression, being transplanted for unconventional malignant indications (colorectal liver metastasis, cholangiocarcinoma) was a risk factor for death HR = 8.93 (95%CI = 1.04–76.63; </span><em>P</em>-value = 0.046). Disease-free survival differs according to different malignant tumours (P-value = 0.045).</p></div><div><h3>Conclusions</h3><p>Post-hepatectomy liver failure is an emergent indication for rescue LT, but it is not universally accepted. In selected patients, LT can be a life-saving procedure with low short-term risks. However, special attention must be given to long-term oncological prognosis before proceeding with rescue LT in an urgent setting, considering the severity of liver malignancy, organ scarcity, the country's organ allocation policies and the resource of living-related donation.</p></div>\",\"PeriodicalId\":48973,\"journal\":{\"name\":\"Transplantation Reviews\",\"volume\":\"37 3\",\"pages\":\"Article 100773\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transplantation Reviews\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0955470X23000277\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation Reviews","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0955470X23000277","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 1

摘要

背景肝切除术后肝功能衰竭是肝大切除术后的一种严重并发症,死亡率高。然而,对于严重的肝功能衰竭没有有效的治疗方法。在这种情况下,抢救性肝移植(LT)仅在结果不明确的特殊情况下使用。本系统综述旨在从患者和无病生存率的角度确定肝切除术后肝功能衰竭的LT指征和LT后的结果,以评估该手术的可行性和有效性。方法对截至2022年9月发表的所有英文全文文章进行系统回顾。纳入标准是描述因肝切除术后肝功能衰竭而接受LT的患者的文章,其中规定了至少一个与患者/移植物存活率、术后并发症、肿瘤复发和死亡原因有关的结果。对数据进行了伪个体参与者数据荟萃分析。使用MINORS系统评估研究质量。PROSPERO CRD42022349358结果术后并发症发生率为53.6%,所有良性适应症移植患者均存活。恶性肿瘤的1年、3年和5年总生存率分别为94.7%、82.1%和74.6%。83.3%的病例死于肿瘤复发,16.7%的LT受者死于感染。在Cox回归分析中,因非常规恶性适应症(结直肠癌、胆管癌)进行移植是死亡的危险因素HR=8.93(95%CI=1.04-76.63;P值=0.046)。不同恶性肿瘤的无病生存率不同(P值=0.045),但它并没有被普遍接受。在选定的患者中,LT可以是一种短期风险较低的挽救生命的手术。然而,在紧急情况下进行LT抢救之前,必须特别注意长期肿瘤学预后,考虑到肝脏恶性肿瘤的严重程度、器官短缺、国家的器官分配政策和与生活相关的捐赠资源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Rescue liver transplantation after post-hepatectomy acute liver failure: A systematic review and pooled analysis

Rescue liver transplantation after post-hepatectomy acute liver failure: A systematic review and pooled analysis

Background

Post-hepatectomy liver failure is a severe complication after major liver resection and is associated with a high mortality rate. Nevertheless, there is no effective treatment for severe liver failure. In such a setting, rescue liver transplantation (LT) is used only in extraordinary cases with unclear results. This systematic review aims to define indication of LT in post-hepatectomy liver failure and post-LT outcomes, in terms of patient and disease-free survivals, to assess the procedure's feasibility and effectiveness.

Methods

A systematic review of all English language full-text articles published until September 2022 was conducted. Inclusion criteria were articles describing patients undergoing LT for post-hepatectomy liver failure after liver resection, which specified at least one outcome of interest regarding patient/graft survival, postoperative complications, tumour recurrence and cause of death. A pseudo-individual participant data meta-analysis was performed to analyse data. Study quality was assessed with MINORS system. PROSPERO CRD42022349358.

Results

Postoperative complication rate was 53.6%. All patients transplanted for benign indications survived. For malignant tumours, 1-, 3- and 5-year overall survival was 94.7%, 82.1% and 74.6%, respectively. The causes of death were tumour recurrence in 83.3% of cases and infection-related in 16.7% of LT recipients. At Cox regression, being transplanted for unconventional malignant indications (colorectal liver metastasis, cholangiocarcinoma) was a risk factor for death HR = 8.93 (95%CI = 1.04–76.63; P-value = 0.046). Disease-free survival differs according to different malignant tumours (P-value = 0.045).

Conclusions

Post-hepatectomy liver failure is an emergent indication for rescue LT, but it is not universally accepted. In selected patients, LT can be a life-saving procedure with low short-term risks. However, special attention must be given to long-term oncological prognosis before proceeding with rescue LT in an urgent setting, considering the severity of liver malignancy, organ scarcity, the country's organ allocation policies and the resource of living-related donation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Transplantation Reviews
Transplantation Reviews IMMUNOLOGY-TRANSPLANTATION
CiteScore
7.50
自引率
2.50%
发文量
40
审稿时长
29 days
期刊介绍: Transplantation Reviews contains state-of-the-art review articles on both clinical and experimental transplantation. The journal features invited articles by authorities in immunology, transplantation medicine and surgery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信